Change of directors at Phorm
TheRegister is reporting that four directors of Phorm have left in what appears to be a difference of opinion between them and CEO Mr Ertugrul.
The board will gain Former Chancellor of the Exchequer Norman Lamont, Investment bankers Stefan Allesch-Taylor and Stephen Partridge-Hicks and Kip Meek who is also the chairman of the telecoms industry lobby group Broadband Stakeholder Group (BSG). For those not aware of the BSG and its role the analysis by The Register covers this.
PC Advisor also reports that the Crown Prosecution Service is collecting evidence to establish whether earlier BT trials of the technology where consent was not sought from participants was legal or otherwise. There is no real news on the progress of the current BT trial and how far away any use of Phorm in its Webwise form is, but given the rate Phorm is burning investment capital it seems safe to assume they would like it to launch before they run out of money.
Some will question if Phorm is trying to buy credibility by surrounding its name with respected people in a battle to change the perceptions its brand has developed; In that light, maybe Phorm wasn't the best of names as it does sound a lot like Phishing (stealing bank login details through a fake website usually by users being confused) and Pharming (redirecting a legitimate site's traffic to fake site).